CARDIFF ONCOLOGY, INC. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
CARDIFF ONCOLOGY, INC. (CRDF) reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $6.15 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2019-08-08
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2019-06-30 was $2.90M, a 80.78% decline year-over-year.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2019-03-31 was $3.24M, a 150.82% increase year-over-year.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2018 was $16.40M.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2017 was -$6.38M, a 377.14% decline from fiscal 2016.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was $2.30M, a 96.43% decline from fiscal 2015.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $64.55M, a 345.68% increase from fiscal 2014.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month as first filed | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 152 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 155 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 158 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 161 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 164 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 167 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 170 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 173 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $6.15M 10-Q · filed 2019-08-08 | $6.15M derived: sum of 3 quarters · filed 2019-08-08 | $6.15M derived: sum of 4 quarters · filed 2019-08-08 | ||||||||||
| 2019-03-31 | $3.24M 10-Q · filed 2019-05-07 | $3.24M derived: sum of 2 quarters · filed 2019-05-07 | $3.24M derived: sum of 3 quarters · filed 2019-05-07 | $18.35M derived: sum of 4 quarters · filed 2019-08-08 | ||||||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | $15.11M derived: sum of 3 quarters · filed 2019-08-08 | $16.40M 10-K · filed 2019-03-06 | ||||||||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $15.11M derived: sum of 2 quarters · filed 2019-08-08 | $16.40M 10-Q · filed 2018-11-07 | $20.47M derived: sum of 4 quarters · filed 2019-08-08 | ||||||||||
| 2018-06-30 | $15.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $16.40M 10-Q · filed 2019-08-08 | $20.47M derived: sum of 3 quarters · filed 2019-08-08 | $26.84M derived: sum of 4 quarters · filed 2019-08-08 | ||||||||||
| 2018-03-31 | $1.29M 10-Q · filed 2019-05-07 | $5.36M derived: sum of 2 quarters · filed 2019-05-07 | $11.73M derived: sum of 3 quarters · filed 2019-05-07 | -$4.93M derived: sum of 4 quarters · filed 2019-05-07 | ||||||||||
| 2017-12-31 | $4.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $10.44M derived: sum of 2 quarters · filed 2019-03-06 | -$6.22M derived: sum of 3 quarters · filed 2019-03-06 | -$6.38M 10-K · filed 2019-03-06 | ||||||||||
| 2017-09-30 | $6.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$10.29M derived: sum of 2 quarters · filed 2018-11-07 | -$10.45M 10-Q · filed 2018-11-07 | -$10.51M derived: sum of 4 quarters · filed 2018-11-07 | ||||||||||
| 2017-06-30 | -$16.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$16.82M 10-Q · filed 2018-08-03 | -$16.88M derived: sum of 3 quarters · filed 2018-08-03 | -$13.22M derived: sum of 4 quarters · filed 2018-08-03 | ||||||||||
| 2017-03-31 | -$156.53K 10-Q · filed 2018-05-08 | -$217.14K derived: sum of 2 quarters · filed 2018-05-08 | $3.44M derived: sum of 3 quarters · filed 2018-05-08 | $2.38M derived: sum of 4 quarters · filed 2018-05-08 | ||||||||||
| 2016-12-31 | -$60.62K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $3.60M derived: sum of 2 quarters · filed 2018-02-26 | $2.54M derived: sum of 3 quarters · filed 2018-02-26 | $2.30M 10-K · filed 2018-02-26 | ||||||||||
| 2016-09-30 | $3.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.60M derived: sum of 2 quarters · filed 2017-11-09 | $2.36M 10-Q · filed 2017-11-09 | $3.49M derived: sum of 4 quarters · filed 2017-11-09 | ||||||||||
| 2016-06-30 | -$1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$1.30M 10-Q · filed 2017-08-09 | -$167.02K derived: sum of 3 quarters · filed 2017-08-09 | $38.39M derived: sum of 4 quarters · filed 2017-08-09 | ||||||||||
| 2016-03-31 | -$235.95K 10-Q · filed 2017-05-10 | $892.71K derived: sum of 2 quarters · filed 2017-05-10 | $39.45M derived: sum of 3 quarters · filed 2017-05-10 | $42.63M derived: sum of 4 quarters · filed 2017-05-10 | ||||||||||
| 2015-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $39.69M derived: sum of 2 quarters · filed 2017-03-15 | $42.87M derived: sum of 3 quarters · filed 2017-03-15 | $64.55M 10-K · filed 2017-03-15 | ||||||||||
| 2015-09-30 | $38.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $41.74M derived: sum of 2 quarters · filed 2016-11-09 | $63.42M 10-Q · filed 2016-11-09 | $63.48M derived: sum of 4 quarters · filed 2017-03-15 | ||||||||||
| 2015-06-30 | $3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $24.87M 10-Q · filed 2016-08-04 | $24.93M derived: sum of 3 quarters · filed 2017-03-15 | $24.93M derived: sum of 4 quarters · filed 2017-03-15 | ||||||||||
| 2015-03-31 | $21.68M 10-Q · filed 2016-05-10 | $21.74M derived: sum of 2 quarters · filed 2017-03-15 | $21.74M derived: sum of 3 quarters · filed 2017-03-15 | $36.21M derived: sum of 4 quarters · filed 2017-03-15 | ||||||||||
| 2014-12-31 | $61.28K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $61.28K derived: sum of 2 quarters · filed 2017-03-15 | $14.53M derived: sum of 3 quarters · filed 2017-03-15 | $14.48M 10-K · filed 2017-03-15 | ||||||||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $14.47M derived: sum of 2 quarters · filed 2015-11-09 | $14.42M 10-Q · filed 2015-11-09 | $14.39M derived: sum of 4 quarters · filed 2016-03-10 | ||||||||||
| 2014-06-30 | $14.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $14.42M 10-Q · filed 2015-08-10 | $14.39M derived: sum of 3 quarters · filed 2016-03-10 | $36.20M derived: sum of 4 quarters · filed 2016-03-10 | ||||||||||
| 2014-03-31 | -$48.64K 10-Q · filed 2015-05-05 | -$78.13K derived: sum of 2 quarters · filed 2016-03-10 | $21.73M derived: sum of 3 quarters · filed 2016-03-10 | $22.87M derived: sum of 4 quarters · filed 2016-03-10 | $59.39M 10-Q · filed 2014-05-12 | |||||||||
| 2013-12-31 | -$29.50K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $21.78M derived: sum of 2 quarters · filed 2016-03-10 | $22.92M derived: sum of 3 quarters · filed 2016-03-10 | $22.98M 10-K · filed 2016-03-10 | $59.43M 10-K · filed 2014-03-17 | |||||||||
| 2013-09-30 | $21.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $22.95M derived: sum of 2 quarters · filed 2014-11-06 | $23.01M 10-Q · filed 2014-11-06 | $27.39M derived: sum of 4 quarters · filed 2015-03-12 | $59.46M 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.21M 10-Q · filed 2014-08-07 | $5.59M derived: sum of 3 quarters · filed 2015-03-12 | $5.58M derived: sum of 4 quarters · filed 2015-03-12 | $37.66M 10-Q · filed 2013-08-14 | |||||||||
| 2013-03-31 | $66.50K 10-Q · filed 2014-05-12 | $4.44M derived: sum of 2 quarters · filed 2015-03-12 | $4.44M derived: sum of 3 quarters · filed 2015-03-12 | $14.50M derived: sum of 4 quarters · filed 2015-03-12 | $36.52M 10-Q · filed 2013-05-14 | |||||||||
| 2012-12-31 | $4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $4.38M derived: sum of 2 quarters · filed 2015-03-12 | $14.43M derived: sum of 3 quarters · filed 2015-03-12 | $15.32M 10-K · filed 2015-03-12 | $36.45M 10-K · filed 2013-04-01 | |||||||||
| 2012-09-30 | -$490.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $10.06M derived: sum of 2 quarters · filed 2013-11-14 | $10.95M 10-Q · filed 2013-11-14 | $24.76M derived: sum of 4 quarters · filed 2015-03-12 | $32.07M 10-Q · filed 2012-11-14 | |||||||||
| 2012-06-30 | $10.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $10.95M 10-Q · filed 2013-08-14 | $24.76M derived: sum of 3 quarters · filed 2015-03-12 | $25.30M derived: sum of 4 quarters · filed 2015-03-12 | $32.07M 10-Q · filed 2012-08-14 | |||||||||
| 2012-03-31 | $889.50K 10-Q · filed 2013-05-14 | $14.70M derived: sum of 2 quarters · filed 2015-03-12 | $15.24M derived: sum of 3 quarters · filed 2015-03-12 | $15.61M derived: sum of 4 quarters · filed 2015-03-12 | $22.02M 10-Q · filed 2012-05-15 | |||||||||
| 2011-12-31 | $13.81M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $14.35M derived: sum of 2 quarters · filed 2015-03-12 | $14.72M derived: sum of 3 quarters · filed 2015-03-12 | $15.32M 10-K · filed 2015-03-12 | $2.57M 10-K · filed 2013-04-01 | |||||||||
| 2011-09-30 | $535.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $910.00K derived: sum of 2 quarters · filed 2012-11-14 | $1.51M 10-Q · filed 2012-11-14 | |||||||||||
| 2011-06-30 | $375.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $975.00K 10-Q · filed 2012-08-14 | ||||||||||||
| 2011-03-31 | $600.00K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |